Currently, there are 225.46M common shares owned by the public and among those 125.44M shares have been available to trade.
The company’s stock has a 5-day price change of 42.49% and 162.84% over the past three months. SANA shares are trading -25.48% year to date (YTD), with the 12-month market performance up to 138.65% higher. It has a 12-month low price of $1.26 and touched a high of $7.40 over the same period. SANA has an average intraday trading volume of 4.10 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 36.30%, 66.80%, and 44.03% respectively.
Institutional ownership of Sana Biotechnology Inc (NASDAQ: SANA) shares accounts for 51.54% of the company’s 225.46M shares outstanding.
It has a market capitalization of $877.41M and a beta (3y monthly) value of 1.85. The earnings-per-share (ttm) stands at -$0.88. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.45% over the week and 11.13% over the month.
Earnings per share for the fiscal year are expected to increase by 34.68%, and 6.84% over the next financial year. EPS should grow at an annualized rate of 14.07% over the next five years, compared to -10.60% over the past 5-year period.
Looking at the support for the SANA, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on July 03, 2025, with the firm’s price target at $12. Citizens JMP coverage for the Sana Biotechnology Inc (SANA) stock in a research note released on March 18, 2025 offered a Mkt Outperform rating with a price target of $5. JMP Securities on their part issued Mkt Perform rating on November 05, 2024.
